We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Riot Blockchain to Acquire Majority Interest in TESS, a Blockchain Development Company Strategic Investment Provides Riot Blockchain with Added Blockchain Development Expertise and Reflects...
Bioptix Changing Name to Riot Blockchain as Company Shifts Focus to Strategic Investor and Operator in Blockchain Technologies Riot Blockchain Announces Strategic Investment in Coinsquare, a...
Bioptix Announces Special Cash Dividend PR Newswire CASTLE ROCK, Colo., Oct. 3, 2017 CASTLE ROCK, Colo., Oct. 3, 2017 /PRNewswire/ -- Bioptix, Inc (NASDAQ: BIOP) (the "Company"), announced today...
Bioptix, Inc. Holds Special Shareholder Meeting Shareholder Support Enables All Proxy Proposals to Pass PR Newswire CASTLE ROCK, Colo., Aug. 23, 2017 CASTLE ROCK, Colo., Aug. 23, 2017...
Bioptix Announces Executive Leadership Change PR Newswire CASTLE ROCK, Colo., April 10, 2017 CASTLE ROCK, Colo., April 10, 2017 /PRNewswire/ -- Bioptix, Inc. (Nasdaq: BIOP) ("Bioptix" or the...
Bioptix Announces Streamlining of Workforce PR Newswire BOULDER, Colo., Jan. 20, 2017 BOULDER, Colo., Jan. 20, 2017 /PRNewswire/ -- Bioptix, Inc. (Nasdaq: BIOP) ("Bioptix" or the "Company...
Bioptix Reports Board of Director Changes PR Newswire BOULDER, Colo., Jan. 6, 2017 BOULDER, Colo., Jan. 6, 2017 /PRNewswire/ -- Bioptix, Inc. (Nasdaq: BIOP), (the "Company"), announced that Gail...
Venaxis Reports Name Change to Bioptix, Inc and NASDAQ Ticker Symbol Change to "BIOP" from "APPY" Trading Change to be Effective December 12, 2016 PR Newswire BOULDER, Colo...
Venaxis Reports Option Inducement Grants for New Employees Under NASDAQ Listing Rule 5635(c)(4) PR Newswire CASTLE ROCK, Colo., Sept. 23, 2016 CASTLE ROCK, Colo., Sept. 23, 2016 /PRNewswire/...
Venaxis Issues Shareholder Update Following Acquisition of BiOptix, Venaxis' CEO Issues Shareholder Letter PR Newswire CASTLE ROCK, Colo., Sept. 20, 2016 CASTLE ROCK, Colo., Sept. 20, 2016...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions